Trials / Completed
CompletedNCT01302028
Renal Impairment Study With ASP1941
An Open-label, Parallel Group Study to Assess the Effect of Different Grades of Renal Impairment in Patients With Type 2 Diabetes Mellitus on the Pharmacokinetics, Pharmacodynamics and Safety & Tolerability of ASP1941 Relative to Type 2 Diabetes Mellitus With Normal Renal Function and Healthy Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 45 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
A study to investigate if the pharmacokinetics of ASP1941 is different in Type 2 Diabetes Mellitus (T2DM) patients with different grades of renal failure compared with T2DM patients with normal renal function and healthy volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | Oral |
Timeline
- Start date
- 2010-01-22
- Primary completion
- 2010-06-26
- Completion
- 2010-06-26
- First posted
- 2011-02-23
- Last updated
- 2017-08-22
Locations
5 sites across 4 countries: Czechia, Hungary, Poland, Slovakia
Source: ClinicalTrials.gov record NCT01302028. Inclusion in this directory is not an endorsement.